Stay updated on Nivolumab for High-Risk Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.
Latest updates to the Nivolumab for High-Risk Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check57 days agoChange DetectedSeveral key URLs related to genetics, prostate cancer, and clinical data have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference5%
- Check65 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to genetics and prostate cancer, including links to MedlinePlus and DailyMed, while removing the previous version 2.12.1.SummaryDifference5%
- Check79 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Nivolumab for High-Risk Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for High-Risk Prostate Cancer Clinical Trial page.